Ramucirumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Ramucirumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ramucirumab included in the composition |
Prices in pharmacies |
| Cyramza | 1645€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 68% Atezolizumab
- 57% Regorafenib
- 45% Nivolumab
- 40% Docetaxel
- 38% Calcium folinate
- 37% Pembrolizumab
- 34% Bevacizumab
- 32% Nimustine
- 32% Topotecan
- 30% Lomustine
- 29% Cetuximab
- 28% Pentagastrin
- 27% Capecitabine
- 26% Carubicin
- 26% Vindesine
- 25% Benzotef
- 25% Daratumumab
- 25% Everolimus
- 25% Epirubicin
- 24% Hydrazine sulfate
- 23% Trastuzumab
- 23% Nintedanib
- 22% Aflibercept
- 21% Fluorouracil
- 21% Tegafur+Uracil [Tegafur]
- 21% Melphalan
- 21% Inonotus Obliquus
- 21% Tegafur
- 20% Irinotecan
- 20% Mitomycin
- 20% Dactinomycin
- 19% Proxifeine
- 19% Tegafur+Gimeracil+Oteracil [Tegafur]
- 18% Gemcitabine
- 18% Teniposide
- 18% Oxaliplatin
- 17% Folinic acid
- 17% Sarcolysin
- 17% Elotuzumab
- 16% Doxorubicin
- 16% Ibandronic acid
- 16% Paclitaxel
- 16% Lorlatinib
- 15% Ipilimumab
- 15% Pantoprazole
- 15% Isatuximab
- 15% Durvalumab
- 14% Rabeprazole
- 14% Pertuzumab
- 14% Lansoprazole
Learn more about the selection of analogues
- The drug has «Ramucirumab» 51 analog by action, the most similar - Atezolizumab .
- Medical online service has selected the best substitutes for Ramucirumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ramucirumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.